About: Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.
Sector: Healthcare
Industry: Pharmaceutical Retailers
Latest price: $3.42 (-0.87%)
SCNX NASDAQ Scienture Holdings, Inc.
Scienture Holdings, Inc. share price
Atividade de preço de SCNX
Último preço
$ 3,420
Variação (24h)
-0,03 USD (0,87%)
Volume
14K
Volume (média 4 sem.)
-
Abertura
$ 3,29
Variação do dia
$ 3,29 - $ 3,47
Fechamento anterior
$ 3,45
Último negócio
04 Nov, 9:00 pm GMT+0
Atrasado
04 Nov, 9:00 pm GMT+0
SCNX price performance
Atrasado
04 Nov, 9:00 pm GMT+0
SCNX details
quote.marketSignals